10-K Filing

REGENXBIO INC. CIK: 1590877 FY 2015

Filing Information

Form Type	10-K
Accession Number	`0001564590-16-013941`
Period End Date	20151231
Filing Date	20160303
Fiscal Year	2015
Fiscal Period	FY
XBRL Instance	rgnx-20151231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 72 Income Statement 109 Cash Flow Statement 84 Stockholders Equity 38

Balance Sheet 72 line items

Line Item	Tag	Value	Unit	Period
Convertible preferred stock, par value	`TemporaryEquityParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Convertible preferred stock, shares authorized	`TemporaryEquitySharesAuthorized`	4.30M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.17M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$54.12M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.12M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.12M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$60.02M	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Trade receivables	`AccountsReceivableNetCurrent`	$805.00K	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	0.00	shares	Point-in-time
Trade receivables	`AccountsReceivableNetCurrent`	$2.14M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Related party receivables	`DueFromRelatedPartiesCurrent`	$750.00K	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Unbilled receivables	`UnbilledReceivablesCurrent`	$327.00K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$28.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$1.02M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	9.50M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$851.00K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	26.31M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$3.03M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	2.65M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$118.15M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	2.65M	shares	Point-in-time
Marketable securities	`MarketableSecuritiesNoncurrent`	$102.23M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	26.31M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	-	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$538.00K	USD	Point-in-time
Cost method investments	`CostMethodInvestments`	$303.00K	USD	Point-in-time
Cost method investments	`CostMethodInvestments`	$300.00K	USD	Point-in-time
Deferred issuance costs	`DeferredCosts`	$157.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$168.00K	USD	Point-in-time
Total assets	`Assets`	$221.38M	USD	Point-in-time
Total assets	`Assets`	$3.49M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.01M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$334.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedExpensesAndOtherCurrentLiabilities`	$1.11M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedExpensesAndOtherCurrentLiabilities`	$3.20M	USD	Point-in-time
Due to related party under services agreement	`DueToRelatedPartiesCurrent`	$1.42M	USD	Point-in-time
Related party promissory notes	`NotesPayableRelatedPartiesClassifiedCurrent`	$2.40M	USD	Point-in-time
Other related party payables	`DueToOtherRelatedPartiesClassifiedCurrent`	$3.76M	USD	Point-in-time
Advance payments	`CustomerAdvancesCurrent`	$153.00K	USD	Point-in-time
Advance payments	`CustomerAdvancesCurrent`	$127.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$9.19M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.34M	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$233.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$4.57M	USD	Point-in-time
Total liabilities	`Liabilities`	$9.19M	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Convertible preferred stock, value	`RedeemableNoncontrollingInterestEquityPreferredCarryingAmount`	$12.59M	USD	Point-in-time
Preferred stock; $0.0001 par value; 10,000 shares authorized, and no shares issued and outstanding at December 31, 2015; no shares authorized, issued and outstanding at December 31, 2014	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock; $0.0001 par value; 10,000 shares authorized, and no shares issued and outstanding at December 31, 2015; no shares authorized, issued and outstanding at December 31, 2014	`PreferredStockValue`	-	USD	Point-in-time
Common stock; $0.0001 par value; 100,000 and 9,500 shares authorized at December 31, 2015 and December 31, 2014, respectively; 26,313 and 2,645 shares issued and outstanding at December 31, 2015 and December 31, 2014, respectively	`CommonStockValue`	$3.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$10.52M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$269.14M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-719.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-51.62M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-28.81M	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquity`	$216.81M	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquity`	$-8.11M	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquity`	$-18.29M	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquity`	$-13.92M	USD	Point-in-time
Total liabilities, convertible preferred stock and stockholders equity (deficit)	`LiabilitiesAndStockholdersEquity`	$221.38M	USD	Point-in-time
Total liabilities, convertible preferred stock and stockholders equity (deficit)	`LiabilitiesAndStockholdersEquity`	$3.49M	USD	Point-in-time

Income Statement 109 line items

Line Item	Tag	Value	Unit	Period
License revenue	`LicensesRevenue`	$5.03M	USD	Annual
License revenue	`LicensesRevenue`	$4.36M	USD	Annual
License revenue	`LicensesRevenue`	$1.05M	USD	Annual
License revenue from related party	`RevenueFromRelatedParties`	$220.00K	USD	Annual
License revenue from related party	`RevenueFromRelatedParties`	$2.00M	USD	Annual
License revenue from related party	`RevenueFromRelatedParties`	$2.70M	USD	Annual
Reagent sales	`OtherSalesRevenueNet`	$257.00K	USD	Annual
Reagent sales	`OtherSalesRevenueNet`	$368.00K	USD	Annual
Reagent sales	`OtherSalesRevenueNet`	$326.00K	USD	Annual
Grant revenue	`RevenueFromGrants`	$306.00K	USD	Annual
Grant revenue	`RevenueFromGrants`	$1.96M	USD	Annual
Grant revenue	`RevenueFromGrants`	$1.22M	USD	Annual
Total revenues	`Revenues`	$644.00K	USD	1 Quarter
Total revenues	`Revenues`	$483.00K	USD	1 Quarter
Total revenues	`Revenues`	$1.14M	USD	1 Quarter
Total revenues	`Revenues`	$6.12M	USD	Annual
Total revenues	`Revenues`	$6.09M	USD	Annual
Total revenues	`Revenues`	$1.15M	USD	1 Quarter
Total revenues	`Revenues`	$4.44M	USD	1 Quarter
Total revenues	`Revenues`	$1.55M	USD	1 Quarter
Total revenues	`Revenues`	$2.94M	USD	1 Quarter
Total revenues	`Revenues`	$1.36M	USD	1 Quarter
Total revenues	`Revenues`	$7.59M	USD	Annual
Licensing costs (including amounts to related parties)	`RelatedPartyCosts`	$151.00K	USD	Annual
Licensing costs (including amounts to related parties)	`RelatedPartyCosts`	$885.00K	USD	Annual
Licensing costs (including amounts to related parties)	`RelatedPartyCosts`	$1.41M	USD	Annual
Costs of reagent sales (including amounts to related parties)	`CostOfGoodsSold`	$122.00K	USD	Annual
Costs of reagent sales (including amounts to related parties)	`CostOfGoodsSold`	$98.00K	USD	Annual
Costs of reagent sales (including amounts to related parties)	`CostOfGoodsSold`	$173.00K	USD	Annual
Research and development (including amounts to related parties)	`ResearchAndDevelopmentExpense`	$5.05M	USD	Annual
Research and development (including amounts to related parties)	`ResearchAndDevelopmentExpense`	$4.96M	USD	Annual
Research and development (including amounts to related parties)	`ResearchAndDevelopmentExpense`	$17.28M	USD	Annual
General and administrative (including amounts to related parties)	`GeneralAndAdministrativeExpense`	$3.85M	USD	Annual
General and administrative (including amounts to related parties)	`GeneralAndAdministrativeExpense`	$11.91M	USD	Annual
General and administrative (including amounts to related parties)	`GeneralAndAdministrativeExpense`	$5.47M	USD	Annual
Foreign currency transaction losses	`ForeignCurrencyTransactionGainLossBeforeTax`	$-14.00K	USD	Annual
Foreign currency transaction losses	`ForeignCurrencyTransactionGainLossBeforeTax`	$-30.00K	USD	Annual
Foreign currency transaction losses	`ForeignCurrencyTransactionGainLossBeforeTax`	$-57.00K	USD	Annual
Other operating income	`OtherOperatingIncome`	$26.00K	USD	Annual
Other operating income	`OtherOperatingIncome`	$47.00K	USD	Annual
Total operating expenses	`CostsAndExpenses`	$2.18M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$9.94M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$30.73M	USD	Annual
Total operating expenses	`CostsAndExpenses`	$9.80M	USD	Annual
Total operating expenses	`CostsAndExpenses`	$8.49M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$10.86M	USD	Annual
Total operating expenses	`CostsAndExpenses`	$2.10M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$3.37M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$4.64M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$7.66M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$2.15M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-3.68M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-23.14M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-4.78M	USD	Annual
Investment income	`InvestmentIncomeNet`	$346.00K	USD	Annual
Interest expense	`InterestExpense`	$321.00K	USD	Annual
Interest expense	`InterestExpense`	$20.00K	USD	Annual
Interest expense	`InterestExpense`	$611.00K	USD	Annual
Total other income (expense)	`OtherNonoperatingIncomeExpense`	$-321.00K	USD	Annual
Total other income (expense)	`OtherNonoperatingIncomeExpense`	$326.00K	USD	Annual
Total other income (expense)	`OtherNonoperatingIncomeExpense`	$-611.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-4.00M	USD	Annual
Net loss	`NetIncomeLoss`	$-4.01M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-672.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-7.33M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-22.81M	USD	Annual
Net loss	`NetIncomeLoss`	$-1.79M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.29M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.18M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.33M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$795.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.39M	USD	Annual
Unrealized loss on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-719.00K	USD	Annual
Total other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-719.00K	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-4.00M	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-23.53M	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-5.39M	USD	Annual
Net loss	`NetIncomeLoss`	$-4.00M	USD	Annual
Net loss	`NetIncomeLoss`	$-4.01M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-672.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-7.33M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-22.81M	USD	Annual
Net loss	`NetIncomeLoss`	$-1.79M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.29M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.18M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.33M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$795.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.39M	USD	Annual
Accretion and dividends on convertible preferred stock	`PreferredStockDividendsAndOtherAdjustments`	$1.75M	USD	Annual
Accretion and dividends on convertible preferred stock	`PreferredStockDividendsAndOtherAdjustments`	$815.00K	USD	Annual
Accretion and dividends on convertible preferred stock	`PreferredStockDividendsAndOtherAdjustments`	$422.00K	USD	Annual
Net gain on extinguishment of convertible preferred stock	`NetGainOnExtinguishmentOfPreferredStockForEarningsPerShare`	$759.00K	USD	Annual
Net loss applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-4.82M	USD	Annual
Net loss applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-5.81M	USD	Annual
Net loss applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-23.80M	USD	Annual
Basic and diluted net loss per common share	`EarningsPerShareBasicAndDiluted`	$-3.24	USD	1 Quarter
Basic and diluted net loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.34	USD	1 Quarter
Basic and diluted net loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.20	USD	1 Quarter
Basic and diluted net loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.94	USD	1 Quarter
Basic and diluted net loss per common share	`EarningsPerShareBasicAndDiluted`	$-1.82	USD	Annual
Basic and diluted net loss per common share	`EarningsPerShareBasicAndDiluted`	$-2.59	USD	Annual
Basic and diluted net loss per common share	`EarningsPerShareBasicAndDiluted`	$0.08	USD	1 Quarter
Basic and diluted net loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.73	USD	1 Quarter
Basic and diluted net loss per common share	`EarningsPerShareBasicAndDiluted`	$-1.52	USD	1 Quarter
Basic and diluted net loss per common share	`EarningsPerShareBasicAndDiluted`	$-2.50	USD	Annual
Basic and diluted net loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.97	USD	1 Quarter
Weighted-average basic and diluted common shares	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	9.17M	shares	Annual
Weighted-average basic and diluted common shares	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	2.32M	shares	Annual
Weighted-average basic and diluted common shares	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	2.64M	shares	Annual

Cash Flow Statement 84 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-4.00M	USD	Annual
Net loss	`NetIncomeLoss`	$-4.01M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-672.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-7.33M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-22.81M	USD	Annual
Net loss	`NetIncomeLoss`	$-1.79M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.29M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.18M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.33M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$795.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.39M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$319.00K	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$2.92M	USD	Annual
Imputed interest on related party promissory notes	`ImputedInterestOnRelatedPartyDebt`	$128.00K	USD	Annual
Imputed interest on related party promissory notes	`ImputedInterestOnRelatedPartyDebt`	$13.00K	USD	Annual
Unrealized foreign currency transaction losses	`ForeignCurrencyTransactionGainLossUnrealized`	$-14.00K	USD	Annual
Unrealized foreign currency transaction losses	`ForeignCurrencyTransactionGainLossUnrealized`	$-44.00K	USD	Annual
Unrealized foreign currency transaction losses	`ForeignCurrencyTransactionGainLossUnrealized`	$-11.00K	USD	Annual
Net amortization of premiums and accretion of discounts on marketable debt securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-311.00K	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	-	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$80.00K	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	-	USD	Annual
Non-cash consideration received for licenses granted	`NonCashConsiderationReceivedForLicensesGrantedOperatingActivity`	$303.00K	USD	Annual
Other non-cash adjustments	`OtherNoncashExpense`	$3.00K	USD	Annual
Trade receivables	`IncreaseDecreaseInAccountsReceivable`	$799.00K	USD	Annual
Trade receivables	`IncreaseDecreaseInAccountsReceivable`	$36.00K	USD	Annual
Trade receivables	`IncreaseDecreaseInAccountsReceivable`	$1.34M	USD	Annual
Related party receivables	`IncreaseDecreaseInDueFromRelatedPartiesCurrent`	$924.00K	USD	Annual
Related party receivables	`IncreaseDecreaseInDueFromRelatedPartiesCurrent`	$-750.00K	USD	Annual
Related party receivables	`IncreaseDecreaseInDueFromRelatedPartiesCurrent`	$-174.00K	USD	Annual
Unbilled receivables	`IncreaseDecreaseInUnbilledReceivables`	$-327.00K	USD	Annual
Unbilled receivables	`IncreaseDecreaseInUnbilledReceivables`	$213.00K	USD	Annual
Unbilled receivables	`IncreaseDecreaseInUnbilledReceivables`	$-109.00K	USD	Annual
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$992.00K	USD	Annual
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$28.00K	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$851.00K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$168.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$257.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$33.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$590.00K	USD	Annual
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$764.00K	USD	Annual
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$107.00K	USD	Annual
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$2.22M	USD	Annual
Due to related party under services agreement	`IncreaseDecreaseInAccountsPayableRelatedParties`	$-34.00K	USD	Annual
Due to related party under services agreement	`IncreaseDecreaseInAccountsPayableRelatedParties`	$768.00K	USD	Annual
Due to related party under services agreement	`IncreaseDecreaseInAccountsPayableRelatedParties`	$3.19M	USD	Annual
Other related party payables	`IncreaseDecreaseInDueToOtherRelatedPartiesCurrent`	$258.00K	USD	Annual
Other related party payables	`IncreaseDecreaseInDueToOtherRelatedPartiesCurrent`	$-41.00K	USD	Annual
Other related party payables	`IncreaseDecreaseInDueToOtherRelatedPartiesCurrent`	$-3.76M	USD	Annual
Advance payments	`IncreaseDecreaseInCustomerAdvances`	$153.00K	USD	Annual
Advance payments	`IncreaseDecreaseInCustomerAdvances`	$-26.00K	USD	Annual
Deferred rent	`IncreaseDecreaseInDeferredRentPayable`	$246.00K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-22.52M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-2.40M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-3.01M	USD	Annual
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$163.28M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$522.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-163.80M	USD	Annual
Proceeds from issuance of Series B preferred units, net of transaction costs	`ProceedsFromIssuanceOfPreferredStockAndPreferenceStock`	$1.97M	USD	Annual
Proceeds from related party promissory notes	`ProceedsFromRelatedPartyDebt`	$2.40M	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$1.00K	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$107.00K	USD	Annual
Proceeds from initial public offering of common stock, net of transaction costs	`ProceedsFromIssuanceInitialPublicOffering`	$145.18M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$1.97M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$2.40M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$239.31M	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$52.99M	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$2.00K	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.05M	USD	Annual
Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.17M	USD	Point-in-time
Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$54.12M	USD	Point-in-time
Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.12M	USD	Point-in-time
Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.12M	USD	Point-in-time
End of period	`CashAndCashEquivalentsAtCarryingValue`	$2.17M	USD	Point-in-time
End of period	`CashAndCashEquivalentsAtCarryingValue`	$54.12M	USD	Point-in-time
End of period	`CashAndCashEquivalentsAtCarryingValue`	$1.12M	USD	Point-in-time
End of period	`CashAndCashEquivalentsAtCarryingValue`	$1.12M	USD	Point-in-time
Cash paid for interest	`InterestPaid`	$164.00K	USD	Annual
Cash paid for interest	`InterestPaid`	$7.00K	USD	Annual
Conversion of related party promissory notes into Series C convertible preferred stock	`DebtConversionConvertedInstrumentAmount1`	$1.39M	USD	Annual
Conversion of convertible preferred stock into common stock upon initial public offering	`ConversionOfStockAmountConverted1`	$111.39M	USD	Annual
Purchases of property and equipment in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$96.00K	USD	Annual
Deferred issuance costs for Series C convertible preferred stock in accrued expenses	`DeferredIssuanceCostsForConvertiblePreferredStockInAccruedExpenses`	$157.00K	USD	Annual
Non-cash consideration received for licenses granted	`NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1`	$303.00K	USD	Annual

Stockholders Equity 38 line items

Line Item	Tag	Value	Unit	Period
Balances (Shares) at December 31, 2012	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Balances (Shares) at December 31, 2012	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Balances at December 31, 2012	`RedeemableNoncontrollingInterestEquityPreferredCarryingAmount`	$12.59M	USD	Point-in-time
Issuance of convertible preferred stock, net of transaction costs	`StockIssuedDuringPeriodValueNewIssues`	$145.18M	USD	Annual
Accretion of preferred units	`PreferredStockAccretionDecrementOfRedemptionDiscount`	$-815.00K	USD	Annual
Accretion of preferred units	`PreferredStockAccretionDecrementOfRedemptionDiscount`	$-1.75M	USD	Annual
Accretion of preferred units	`PreferredStockAccretionDecrementOfRedemptionDiscount`	$-422.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-4.00M	USD	Annual
Net loss	`NetIncomeLoss`	$-4.01M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-672.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-7.33M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-22.81M	USD	Annual
Net loss	`NetIncomeLoss`	$-1.79M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.29M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.18M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.33M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$795.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.39M	USD	Annual
Balances (Shares) at December 31, 2013	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Balances (Shares) at December 31, 2013	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Balances at December 31, 2013	`RedeemableNoncontrollingInterestEquityPreferredCarryingAmount`	$12.59M	USD	Point-in-time
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.00K	USD	Annual
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$107.00K	USD	Annual
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.92M	USD	Annual
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$319.00K	USD	Annual
Loss (gain) on extinguishment of convertible preferred stock	`GainLossOnExtinguishmentOfConvertiblePreferredStock`	$-759.00K	USD	Annual
Conversion of convertible preferred stock into common stock upon initial public offering	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$111.39M	USD	Annual
Unrealized loss on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-719.00K	USD	Annual
Balances at December 31, 2012	`StockholdersEquity`	$216.81M	USD	Point-in-time
Balances at December 31, 2012	`StockholdersEquity`	$-8.11M	USD	Point-in-time
Balances at December 31, 2012	`StockholdersEquity`	$-18.29M	USD	Point-in-time
Balances at December 31, 2012	`StockholdersEquity`	$-13.92M	USD	Point-in-time
Balances at December 31, 2013	`StockholdersEquity`	$216.81M	USD	Point-in-time
Balances at December 31, 2013	`StockholdersEquity`	$-8.11M	USD	Point-in-time
Balances at December 31, 2013	`StockholdersEquity`	$-18.29M	USD	Point-in-time
Balances at December 31, 2013	`StockholdersEquity`	$-13.92M	USD	Point-in-time
Discount on Related Party Promissory Notes	`DiscountOnRelatedPartyPromissoryNotesValues`	$128.00K	USD	Annual
Discount on Related Party Promissory Notes	`DiscountOnRelatedPartyPromissoryNotesValues`	$13.00K	USD	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.